These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35331585)

  • 1. Efficacy of breast conservative surgery versus modified radical mastectomy for triple-negative breast cancer: A systematic review and meta-analysis.
    Wu HX; Lin ZW; Song TY; Piao YS
    Asian J Surg; 2022 Jul; 45(7):1491-1493. PubMed ID: 35331585
    [No Abstract]   [Full Text] [Related]  

  • 2. Conservative surgery plus axillary radiotherapy vs. modified radical mastectomy in patients with stage I breast cancer.
    Chen D; Lai L; Duan C; Yan M; Xing M; Chen J; Zhang F
    Clin Breast Cancer; 2014 Feb; 14(1):e10-3. PubMed ID: 24201162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on: Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
    Wei H; Bao W; Zhu D; Guo S
    Br J Surg; 2022 Feb; 109(2):e47-e48. PubMed ID: 34875025
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment on: Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: Meta-analysis.
    Wang S; Li Y; Chen J
    Br J Surg; 2022 Feb; 109(2):e45. PubMed ID: 34850852
    [No Abstract]   [Full Text] [Related]  

  • 6. Is breast conservation therapy superior to mastectomy for women with triple-negative breast cancers?
    Pignol JP; Rakovitch E; Olivotto IA
    J Clin Oncol; 2011 Jul; 29(21):2841-3. PubMed ID: 21670459
    [No Abstract]   [Full Text] [Related]  

  • 7. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
    Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local recurrence based on size after conservative surgery in breast cancer stage T1-T2. A population-based study].
    Martínez-Ramos D; Fortea-Sanchis C; Escrig-Sos J; Prats-de Puig M; Queralt-Martín R; Salvador-Sanchis JL
    Cir Cir; 2014; 82(3):252-61. PubMed ID: 25238466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast conservation versus mastectomy in triple-negative breast cancer: two steps forward, one step back?
    Trainer AH; James PA; Mann GB; Lindeman GJ
    J Clin Oncol; 2011 Dec; 29(35):4722-3; author reply 4723-4. PubMed ID: 22042938
    [No Abstract]   [Full Text] [Related]  

  • 11. Does addition of postmastectomy radiotherapy improve outcome of patients with pT1-2, N0 triple negative breast cancer as compared to breast conservation therapy?
    Raghavan RK; Ibrahim S; Jagathnath Krishna KM; Mathew BS
    J Cancer Res Ther; 2019; 15(5):1031-1034. PubMed ID: 31603106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence risk after previous salvage mastectomy.
    Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study.
    Dragun AE; Pan J; Rai SN; Kruse B; Jain D
    Am J Clin Oncol; 2011 Jun; 34(3):231-7. PubMed ID: 20805742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Author response to: Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
    Fancellu A; Ninniri C; Marinovich ML
    Br J Surg; 2022 Feb; 109(2):e46. PubMed ID: 34910101
    [No Abstract]   [Full Text] [Related]  

  • 15. Author response to: Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
    Fancellu A; Marinovich ML
    Br J Surg; 2022 Feb; 109(2):e49. PubMed ID: 34850829
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
    Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
    Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is conservative surgery a good option for patients with "triple negative" breast cancer?
    Martinez-Ramos D; Escrig-Sos J; Torrella-Ramos A; Alcalde-Sanchez M; Salvador-Sanchis JL
    Breast; 2012 Jun; 21(3):401-5. PubMed ID: 22579462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer.
    Zumsteg ZS; Morrow M; Arnold B; Zheng J; Zhang Z; Robson M; Traina T; McCormick B; Powell S; Ho AY
    Ann Surg Oncol; 2013 Oct; 20(11):3469-76. PubMed ID: 23686101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.